cBrain A/S : The technical configuration is positive
| Entry price | Target | Stop-loss | Potential |
|---|
|
DKK 238 |
DKK 375 |
DKK 166 |
+57.56% |
|---|
Shares in cBrain A/S do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Strengths● The company returns high margins, thereby supporting business profitability.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
CBRAIN A/S 
